Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence of a Test Formulation of Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories) Under Fasted Conditions

NCT02086227 is registered in ClinicalTrials.gov with Fresenius Kabi USA, LLC as lead sponsor.

NCT NCT02086227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02086227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence of a Test Formulation of Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories) Under Fasted Conditions
Lead sponsor
Fresenius Kabi USA, LLC
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2013
Completion date
June 30, 2013
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoglycemia